Conference abstractPublished 29 Mar 2018
Brain free hemoglobin increase is different among anticoagulant classes
The Ohio State University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background & Aim: Anticoagulant therapy is broadly used to prevent thromboembolic events. Intracranial hemorrhages are serious complications of anticoagulation, especially with vitamin K inhibitors, including warfarin. Novel direct oral anticoagulants (DOAC) reduce, but not completely eliminate the risk of intracranial hemorrhages. The aim of this study was to investigate the severity of brain hemorrhages as measured by free hemoglobin in the brain parenchyma, among different anticoagulant classes in rats. Methods: Rats were treated with excessive doses (LD50) of different anticoagulant classes (vitamin K antagonists, including brodifacoum and warfarin, heparin, direct thrombin inhibitor and factor Xa inhibitor). Free hemoglobin concentration was measured in the brain. Results: Vitamin K antagonists resulted in significant increase in free hemoglobin in the brain. Among DOAC, direct thrombin inhibitor dabigatran also increased free hemoglobin in the brain, whereas treatment with factor Xa inhibitor rivaroxaban did not have effect on free hemoglobin concentration. Conclusion: Our data indicate that different anticoagulant class result in different accumulation of free hemoglobin in the brain and it is more pronounced with vitamin K inhibitors.
Subjects
ToxicologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalToxicology: Open Access
- SubjectToxicology
- BylineArticles whose byline prints “Sergey V Brodsky”